Table 1.
Methods for the assessment of intestinal barrier integrity status and intestinal barrier function loss
Test | Measured in | Indicative for | Tissue specificity |
I-FABP | Blood or urine | Intestinal epithelial integrity | Yes (predominantly proximal small gut) |
Single sample | |||
I-BABP | Blood or urine | Intestinal epithelial integrity | Yes (predominantly ileum) |
Single sample | |||
L-FABP | Blood or urine | Intestinal epithelial integrity | No |
Single sample | |||
GST-α | Blood | Intestinal epithelial integrity | No |
Single sample | |||
Claudin 3 | Urine | Paracellular integrity | No |
Single sample | |||
Dual Sugar Test | Urine | Functional intestinal barrier function | Yes |
5 h collection | |||
PEG | Urine | Functional intestinal barrier function | Yes |
6 h collection | |||
51Cr-EDTA | Urine | Functional intestinal barrier function | Yes |
24 h collection | |||
LAL-assay | Blood | Intestinal barrier function | N/A |
Single sample | |||
EndoCAb | Blood | Intestinal barrier function | N/A |
Single sample | |||
D-Lactate | Blood | Intestinal barrier function | Yes |
Single sample |
I-FABP: Intestinal fatty acid binding protein; I-BABP: Ileal bile acid binding protein; GST: Glutathione S-transferase-α; PEG: Polyethylene glycol;
Cr-EDTA: Chromium labelled EDTA; LAL: Limulus amebocyte lysate; EndoCAb: Endotoxin core antibody; N/A: Not applicable.